Residual risk of transfusion transmitted human immunodeficiency virus, hepatitis B virus, hepatitis C virus and human T lymphotrophic virus

New Testing Strategy to Detect Early HIV-1 Infection for Use in Incidence Estimates and for Clinical and Prevention Purposes

1998 • 698 citations

Current prevalence and incidence of infectious disease markers and estimated window‐period risk in the American Red Cross blood donor population

2002 • 666 citations

A new strategy for estimating risks of transfusion‐transmitted viral infections based on rates of detection of recently infected donors

2005 • 421 citations

Serious hazards of transfusion (SHOT) initiative: analysis of the first two annual reports

1999 • 334 citations

The cost‐effectiveness of NAT for HIV, HCV, and HBV in whole‐blood donations

2003 • 267 citations

A prospective study of transmission by transfusion of HTLV‐I and risk factors associated with seroconversion

1992 • 247 citations

The incidence/window period model and its use to assess the risk of transfusion-transmitted human immunodeficiency virus and hepatitis C virus infection

1997 • 171 citations

International application of the Incidence Rate/Window Period model

2002 • 150 citations

Effect of concurrent acute infection with hepatitis C virus on acute hepatitis B virus infection.

1993 • 144 citations

Occult hepatitis B virus infection

2004 • 144 citations

Cost‐effectiveness of nucleic acid test screening of volunteer blood donations for hepatitis B, hepatitis C and human immunodeficiency virus in the United States

2004 • 140 citations

Estimation of the risk of hepatitis B virus, hepatitis C virus and human immunodeficiency virus infectious donations entering the blood supply in England, 1993–2001

2003 • 133 citations

Incidence and estimated rates of residual risk for HIV, hepatitis C, hepatitis B and human T-cell lymphotropic viruses in blood donors in Canada, 1990-2000.

2003 • 130 citations

Should HBV DNA NAT replace HBsAg and/or anti-HBc screening of blood donors?

2004 • 103 citations

A method for estimating hepatitis B virus incidence rates in volunteer blood donors. National Heart, Lung, and Blood Institute Retrovirus Epidemiology Donor Study

1997 • 90 citations

Don't bug me: the problem of bacterial contamination of blood components—challenges and solutions

2001 • 81 citations

Assessing the accuracy of three viral risk models in predicting the outcome of implementing HIV and HCV NAT donor screening in Australia and the implications for future HBV NAT

2002 • 77 citations

Results of Viral Marker Screening of Unpaid Blood Donations and Probability of Window Period Donations in 1997

2000 • 77 citations

Blood Safety in the New Millennium

2002 • 70 citations

Redefining the HIV‐infectious window period in the chimpanzee model: evidence to suggest that viral nucleic acid testing can prevent blood‐borne transmission

1999 • 67 citations

The risks of transfusion-transmitted infection: direct estimation and mathematical modelling

2000 • 63 citations

Sensitivity of HCV RNA and HIV RNA blood screening assays

2002 • 61 citations

A cost‐effectiveness analysis of the use of a mechanical barrier system to reduce the risk of mistransfusion

1996 • 57 citations

The risk of transmitting HCV, HBV or HIV by blood transfusion in Victoria

1997 • 54 citations

Results of Viral Marker Screening of Unpaid Blood Donations and Probability of Window Period Donations in 1997

2000 • 45 citations

The UK blood transfusion service: over a (patent) barrel?

2002 • 37 citations

Variant Creutzfeldt‐Jakob disease in Australian blood donors: estimation of risk and the impact of deferral strategies

2001 • 25 citations